At the end of March, DNA-Technology took a part in the international symposium "News in microbiological diagnosis and therapy of infections – The future is now" in Serbia.
+7 495 640-17-71
info@dna-technology.com
ENG
RUS
X
Menu
At the end of March, DNA-Technology took a part in the international symposium "News in microbiological diagnosis and therapy of infections – The future is now" in Serbia.
We glad to present a new booklet on the test Androflor®, which clearly and concisely formed answers to questions such as - why to choice this test, indications for use, particularities of biomaterial collection and the obtained results interpretation.
It's a new complex analysis to quantify the gut microbiota composition of 0-14 years old children. The technology based on real-time PCR, one of the most accurate and fastest method, which allows to detect 99,9% of microorganism species of children's gut microbiota.
We have already announced our participation in the upcoming World Health Expo Labs (WHX) in Dubai.
Today, we are pleased to announce booth presentation at stand S1.H01, which will be delivered by DNA-Technology during the WHX.
Our experts will present the latest developments in PCR diagnostics and discuss their application in clinical practice.
Together with top industry experts and leaders in laboratory diagnostics, we are welcoming new technologies and innovations that are shaping the future of healthcare.
As the year comes to a close, it is time to review and reassess. It has been a challenging, but at the same time incredibly eventful and bright year for us.
We have significantly expanded our global presence by entering new markets.
hat we value most is that our professional relationships with you continue to strengthen and grow into sincere, friendly bonds.
Our partner — the company ECMIG — continues to strengthen international dialogue in the field of veterinary medicine.
From October 30 to November 2, 2025, our company took part in the international conference MICROCON 2025, dedicated to clinical microbiology and infectious diseases.
In October 2025, DNA-Technology and ITGEL Eruul Mend held a large-scale scientific seminar - workshop in Ulaanbaatar to celebrate 10 years of successful partnership.
DNA-Technology took part in the international business mission for export-oriented industrial enterprises of Moscow, organized by MOSPROM From October 5 to 9, 2025.
DNA-Technology has participated and successfully passed an external quality assessment by QCMD (Quality Control for Molecular Diagnostics) for the HPV PRESS-25 and HPV SURE-25 panels.
QCMD programs are globally recognized and are conducted in collaboration with leading expert centers and organizations, including the World Health Organization (WHO).
The study used the HPV QUANT-21 Quantitative REAL-TIME PCR Kit, HPV SCREEN HR14(16-18-45) REAL-TIME PCR Kit and FEMOFLOR®II reagent kits, which demonstrated 100% result concordance across all samples in both programs.
